# Travere Therapeutics, Inc.: Form 8-K/A, filed May 1, 2025

- Company: [Travere Therapeutics, Inc.](/companies/tvtx.md) (CIK 1438533)
- Form: 8-K/A
- Filed: 2025-05-01
- Accepted by EDGAR: May 1, 2025, 17:21 ET
- Period: 2025-05-01
- Accession: 0001438533-25-000030
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1438533/000143853325000030/tvtx-20250501.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1438533/000143853325000030/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1438533/000143853325000030/tvtx-20250501.htm

Filed May 1, 2025.
Source: SEC EDGAR, the filing index for accession 0001438533-25-000030. Last ingested by Listed: Nov 5, 2026, 14:02 ET. No prices; not investment advice.